Clinical trials phase 2 with new drug ESK 981

[donits]

Unleashing immunotherapy against "cold" prostate tumors. (Michigan Rogel Cancer Center) Any comments?

[Tall_Allen]

Good luck! Let us know if it works for you.

[donits in reply to Tall_Allen]

Hi Tall_Allen, here are some details of this study. The University of Michigan Rogel Cancer Center has now launched a phase 2 clinical trial of the combination in patients with metastatic, castrate-resistant prostate cancer. The drug tested by the University team. ESK 981 (previously known as CEP-11981), was tested in a phase 1 trial and found to be safe and well-tolerated. Source: Fierce Biotech/by Arlene Weintraub Aug 2.21.Another topic: Researchers uncover a way to harness the power of immunotherapy for advanced prostate cancer. Source: Medical Xpress.

As a result, I cannot participate in the study as I am not yet castration-resistant.

BTW, I posted the full text on this topic on the forum but my post has been deleted. I also received this message:

"From Jerry,

Hi there, I`ve deleted your post as it`s off-topic but here`s the HealthUnlocked Prostate cancer community where it will be very revalant. Thank you for your understanding,

Jerry"

Unfortunately, I don`t understand what`s going on here. Maybe someone explains to me please.

Best greetings to All.